Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To get information on drug patent expirations
— Analyst, USA
For information about patents on drugs of interest
— Information consultant, Mexico
To find drug patent expirations in the North Africa market
— Business development, India
To study exclusivity periods for a number of drugs
— Pharmaceutical company, Canada
To identify patent expiry dates for Canada and the USA
— Pharmacy services, Canada
Generated: May 24, 2017
What are the generic drug sources for teduglutide recombinant and what is the scope of teduglutide recombinant patent protection?
Teduglutide recombinant is the generic ingredient in one branded drug marketed by Nps Pharms Inc and is included in one NDA. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.| Tradenames: | 1 |
| Patents: | 12 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: see list | 1 |
| Suppliers / Packagers: see list | 1 |
| Clinical Trials: see list | 618 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | teduglutide recombinant at DailyMed |
| Ingredient-type | Glucagon-Like Peptide 2 Analogs/Derivatives |
| Drug Class | GLP-2 Analog |
| Mechanism of Action | Glucagon-like Peptide-2 (GLP-2) Agonists |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nps Pharms Inc | GATTEX KIT | teduglutide recombinant | POWDER;SUBCUTANEOUS | 203441-001 | Dec 21, 2012 | RX | Yes | Yes | 9,545,435 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Nps Pharms Inc | GATTEX KIT | teduglutide recombinant | POWDER;SUBCUTANEOUS | 203441-001 | Dec 21, 2012 | RX | Yes | Yes | 9,592,274 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Nps Pharms Inc | GATTEX KIT | teduglutide recombinant | POWDER;SUBCUTANEOUS | 203441-001 | Dec 21, 2012 | RX | Yes | Yes | 9,555,079 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Nps Pharms Inc | GATTEX KIT | teduglutide recombinant | POWDER;SUBCUTANEOUS | 203441-001 | Dec 21, 2012 | RX | Yes | Yes | 9,592,273 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Nps Pharms Inc | GATTEX KIT | teduglutide recombinant | POWDER;SUBCUTANEOUS | 203441-001 | Dec 21, 2012 | RX | Yes | Yes | ► Subscribe | ► Subscribe | |||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Expired Orange Book Patents
Available with subscription
Paragraph IV Activity
Available with subscription
Patent Maintenance
Available with subscription
Non-Orange Book Patents
Available with subscription
International Patents
Available with subscription
Supplementary Protection Certificates
Available with subscription
To get information on international drug patents
— Patent agent, USA
To apply for a patent
— Pharmaceutical researcher, USA
To get nformation about pending patent expiries in the pharmaceutical market
— Sales, Sweden
To gather valuable information on past, current, and future/prospective diabetes products
— Pharmacist, Luxembourg
For patent information on specific drug portfolios
— Consultant, USA
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
